These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8780859)

  • 1. Melatonin secretion during fluvoxamine treatment in medicated chronic schizophrenic patients: evidence for the development of tolerance to selective serotonin re-uptake inhibitor.
    Silver H; Barash I; Odnopozov N; Jahjah N; Mizruhin A
    Biol Psychiatry; 1996 Jul; 40(1):75-7. PubMed ID: 8780859
    [No Abstract]   [Full Text] [Related]  

  • 2. Add-on fluvoxamine and negative symptoms of schizophrenia: analysis of data from augmentation studies in a single center.
    Silver H; Bilker WB
    J Clin Psychopharmacol; 2013 Oct; 33(5):710-1. PubMed ID: 23899641
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluvoxamine augmentation in risperidone-resistant schizophrenia: an open trial.
    Takahashi H; Sugita T; Higuchi H; Shimizu T
    Hum Psychopharmacol; 2002 Mar; 17(2):95-8. PubMed ID: 12404698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients.
    Lu ML; Lane HY; Chen KP; Jann MW; Su MH; Chang WH
    J Clin Psychiatry; 2000 Aug; 61(8):594-9. PubMed ID: 10982203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
    Andrade C
    J Clin Psychiatry; 2012 Nov; 73(11):e1362-4. PubMed ID: 23218164
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: a preliminary study.
    Niitsu T; Fujisaki M; Shiina A; Yoshida T; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Fukami G; Nakazato M; Shirayama Y; Hashimoto K; Iyo M
    J Clin Psychopharmacol; 2012 Oct; 32(5):593-601. PubMed ID: 22926591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study.
    Silver H; Shmugliakov N
    J Clin Psychopharmacol; 1998 Jun; 18(3):208-11. PubMed ID: 9617979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile.
    Grözinger M; Härtter S; Wang X; Röschke J; Hiemke C; Rose DM
    Arch Gen Psychiatry; 2000 Aug; 57(8):812-3. PubMed ID: 10920471
    [No Abstract]   [Full Text] [Related]  

  • 9. A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
    Sunami E; Usuda K; Nishiyama Y; Otori T; Katsura K; Katayama Y
    Intern Med; 2012; 51(10):1187-93. PubMed ID: 22687788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder.
    Dell'Osso B; Allen A; Hollander E
    Expert Opin Pharmacother; 2005 Dec; 6(15):2727-40. PubMed ID: 16316311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia.
    Yasui-Furukori N; Kondo T; Mihara K; Inoue Y; Kaneko S
    Psychopharmacology (Berl); 2004 Jan; 171(2):223-7. PubMed ID: 12955290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine improved cognitive impairments in a patient with schizophrenia.
    Niitsu T; Shirayama Y; Fujisaki M; Hashimoto K; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1345-6. PubMed ID: 20600473
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine plus fluvoxamine and olanzapine alone for the treatment of an acute exacerbation of schizophrenia.
    Chaichan W
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):364-8. PubMed ID: 15298648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia.
    Dwivedi S; Pavuluri M; Heidenreich J; Wright T
    J Child Adolesc Psychopharmacol; 2002; 12(1):69-70. PubMed ID: 12014598
    [No Abstract]   [Full Text] [Related]  

  • 15. [SSRI antidepressants and negative schizophrenic symptoms: differences between paroxetine and fluvoxamine in patients treated with olanzapine].
    Rusconi AC; Carlone C; Muscillo M; Coccanari de' Fornari MA; Podda L; Piccione M
    Riv Psichiatr; 2009; 44(5):313-9. PubMed ID: 20066819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia: A 12-week, randomized, double-blind, placebo-controlled study.
    Lu ML; Chen TT; Kuo PH; Hsu CC; Chen CH
    Schizophr Res; 2018 Mar; 193():126-133. PubMed ID: 28688742
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Boyle K; Cornett S; Fijtman A; Hunt-Harrison T
    J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):514-515. PubMed ID: 34166111
    [No Abstract]   [Full Text] [Related]  

  • 18. [Additional treatment in chronic pain syndrome due to hip and knee arthritis with the selective serotonin reuptake inhibitor fluvoxamine (Fevarin].
    Riesner HJ; Zeitler C; Schreiber H; Wild A
    Z Orthop Unfall; 2008; 146(6):742-6. PubMed ID: 19085723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
    Wetzel H; Anghelescu I; Szegedi A; Wiesner J; Weigmann H; Härter S; Hiemke C
    J Clin Psychopharmacol; 1998 Feb; 18(1):2-9. PubMed ID: 9472836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia.
    Silver H
    Expert Opin Pharmacother; 2004 Oct; 5(10):2053-8. PubMed ID: 15461540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.